Lamictal | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lamictal
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Lamictal

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

64 API Suppliers, 34 USDMF, 21 CEP/COS, 5 JDMF, 21 EU WC, 9 KDMF, 22 NDC API, 37 Listed Suppliers, $ API Reference Price

64 API Suppliers
34 USDMF
21 CEP/COS
5 JDMF
21 EU WC
9 KDMF
22 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1080 FDF Dossiers, 230 FDA Orange Book, 597 Europe, 38 Canada, 74 Australia, 70 South Africa, 71 Listed Dossiers

1080 FDF Dossiers
230 FDA Orange Book
597 Europe
38 Canada
74 Australia
70 South Africa
71 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG
TABLET;ORAL - 150MG
TABLET;ORAL - 200MG
TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Evonik, 5 Rochem International Inc, 23 SPI Pharma, 2 Seqens, 6 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 9 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 ACG Worldwide, 8 Actylis, 3 Aeon Procare, 4 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 4 Doshion Polyscience, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

102 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 51 Disintegrants & Superdisintegrants, 47 Direct Compression, 45 Controlled & Modified Release, 44 Taste Masking, 34 Granulation, 33 Solubilizers, 27 Thickeners and Stabilizers, 26 Lubricants & Glidants, 26 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 19 Parenteral, 15 Topical, 7 API Stability Enhancers, 7 Emulsifying Agents, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules

102 Fillers, Diluents & Binders
82 Coating Systems & Additives
51 Disintegrants & Superdisintegrants
47 Direct Compression
45 Controlled & Modified Release
44 Taste Masking
34 Granulation
33 Solubilizers
27 Thickeners and Stabilizers
26 Lubricants & Glidants
26 Film Formers & Plasticizers
23 Chewable & Orodispersible Aids
20 Co-Processed Excipients
19 Parenteral
15 Topical
7 API Stability Enhancers
7 Emulsifying Agents
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

42 NEWS #PharmaBuzz

42 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 225 Finished Drug Prices, 10 Annual Reports

4 US Medicaid Prescriptions
225 Finished Drug Prices
10 Annual Reports

MARKET PLACE

10 APIs, 5 FDF Dossiers

10 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 6 Health Canada Patents

6 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 12 Others

4 EDQM
1 USP
12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 132 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6GlaxoSmithKline Inc.

filter Patent Reset all filters

6 All

01 62277722

filter Product Reset all filters

6 All

01 6Lamotrigine

filter Dosage Reset all filters

6 All

01 6Chewable Dispersible Tablets

filter Exp Date Reset all filters

6 All

01 62012-01-29

IOL Lamotrigine

Product Main Page

01

GlaxoSmithKline Inc.

Lamotrigine

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 5mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Lamotrigine

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 25mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Lamotrigine

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 50mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Lamotrigine

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 100mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Lamotrigine

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 200mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GlaxoSmithKline Inc.

Lamotrigine

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 2mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!